The
phytosterols
market is expected to witness a significant growth during the
forecast period especially in the developing countries such as India
and China. Consumer awareness for health and wellness along with the
adoption of a healthier lifestyle is fuelling the demand for
phytosterols market in these regions.
Phytosterols
are inclusive of plant sterols and plant stanols. Saturated sterols,
which lack double bond in the sterol ring are called stanols.
Phytosterols resemble cholesterols, but the variation is visible in
the carbon side chain and the prevalence or absence of a carbon
double bond. The main difference between phytosterols and cholesterol
lies in the absorption levels in the blood stream. Cholesterols are
absorbed in the blood, thereby increasing the cholesterol level in
the human body which in turn increases the incidences of coronary
heart diseases. Phytosterols, on the other hand are not absorbed by
the body and are present at low levels. Due to their chemical
resemblance, phytosterols block cholesterol from being absorbed by
the blood, thereby reducing the triglyceride level in the human body.
Rising
incidences of deaths due to cardiovascular diseases especially in the
developed regions such as Europe and North America is propelling the
demand for the phytosterols. Phytosterols are almost similar to
cholesterols, but they act as blockages for cholesterol and prevent
the absorption of the same in the blood stream. This reduces the
triglyceride level in the human body, which in turn reduces the
incidences of coronary heart diseases.
Availability
of omega 3 fatty acids (EPA/DHA) is impeding the growth of the global
phytosterols market as the market share of omega 3 fatty acids is
more compared to phytosterols, due to which the manufacturers are
shifting towards omega 3 fatty acid ingredients. Lack of support from
the governing bodies in the developing regions such as Asia Pacific
and Middle East regarding the health benefits offered by phytosterols
is impeding the growth of the phytosterols market. This has led to
the low awareness about the benefits of phytosterols among the
consumers in the developing regions.
View
exclusive Global strategic Business report
:http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=747
B-sitosterol
held the largest market share in the global phytosterols market on
account of the widespread availability of its source. Campesterol
accounted for the second largest market share in the global
phytosterols market and it is expected to witness a significant
growth owing to its anti-inflammatory properties. The others segment
is inclusive ergosterol and brassicasterol and this segment accounted
for the lowest market share in 2014.
Europe
dominated the global phytosterols market with a market share of over
40% and is expected to retain its position in the future. North
America is the second largest market for phytosterols. However, Rest
of the World is the fastest growing market for phytosterols. The
rapid growth is mainly attributed to the increasing awareness of the
consumers about the benefits of phytosterols. The increasing
consumption of phytosterol fortified products in medical application
owing to the growing number of coronary heart diseases is also
fuelling the demand for the phytosterols market in Rest of the World.
The
global phytosterols market is marked by some tough competition from
the major players operating in this market. Frequent mergers and
acquisitions, partnerships, and joint ventures among others are some
of the major strategies adopted by these players to sustain in the
global phytosterols market. Archer Daniels Midlands Co, BASF SE,
Bunge Ltd, Cargill Inc, Raisio plc, Arboris LLC, Pharmachem
Laboratories are some of the major players operating in the global
phytosterols market.
No comments:
Post a Comment